Status:

UNKNOWN

Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease

Lead Sponsor:

VIFORFRANCE

Conditions:

Intestinal Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Despite its known prevalence in IBD, a recent study conducted with Prof. Cacoub (unpublished) on the national health insurance database showed that iron deficiency was an under-diagnosed and under-tre...

Eligibility Criteria

Inclusion

  • Patient, male or female, over 18 years old
  • Patient present at the hospital on the day of the study
  • Diagnosis of IBD on international criteria
  • Patient giving written consent

Exclusion

  • Protected patient: major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision;
  • pregnant, lactating or parturient woman;
  • Patient hospitalized without consent

Key Trial Info

Start Date :

November 2 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 30 2020

Estimated Enrollment :

1100 Patients enrolled

Trial Details

Trial ID

NCT04123990

Start Date

November 2 2019

End Date

March 30 2020

Last Update

October 11 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Study of the Prevalence of Iron Deficiency in Patients With Chronic Inflammatory Bowel Disease | DecenTrialz